Citius Oncology Inc (CTOR)

10:49 AM

Is Citius Oncology Inc. a candidate for recovery playStock Surge & Safe Swing Trade Setup Alerts - newser.com

10:49 AM

10:49 AM

Sector ETF performance correlation with Citius Oncology Inc.July 2025 Rallies & Safe Swing Trade Setup Alerts - newser.com

10:49 AM

07:14 AM

Is Citius Oncology Inc. stock bottoming outOil Prices & Target Return Focused Stock Picks - newser.com

07:14 AM

05:48 AM

Heatmap analysis for Citius Oncology Inc. and competitorsMarket Sentiment Summary & Precise Swing Trade Alerts - newser.com

05:48 AM

02:48 AM

Why Citius Oncology Inc. stock is recommended by analystsJuly 2025 Summary & Verified Technical Signals - newser.com

02:48 AM

Oct 09, 2025

Citius Oncology's (CTOR) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat

Oct 09, 2025

Oct 09, 2025

How Citius Oncology Inc. stock benefits from tech adoptionWeekly Stock Summary & Long-Term Growth Stock Strategies - newser.com

Oct 09, 2025

Oct 09, 2025

How Citius Oncology Inc. stock performs in stagflationTrade Risk Summary & Low Drawdown Trading Strategies - newser.com

Oct 09, 2025

Oct 09, 2025

What to do if you’re stuck in Citius Oncology Inc.2025 Support & Resistance & Weekly Momentum Picks - newser.com

Oct 09, 2025

Oct 09, 2025

Will a bounce in Citius Oncology Inc. offer an exitMarket Movement Recap & Safe Entry Zone Identification - newser.com

Oct 09, 2025

Oct 09, 2025

Has Citius Oncology Inc. formed a bullish divergenceVolume Spike & Daily Volume Surge Signals - newser.com

Oct 09, 2025

Oct 09, 2025

Is it time to cut losses on Citius Oncology Inc.Trade Volume Report & Real-Time Stock Price Movement Reports - newser.com

Oct 09, 2025

Oct 08, 2025

Citius in talks over Lymphir access in global markets - The Pharma Letter

Oct 08, 2025

Oct 07, 2025

Citius Sets Up Access to Lymphir in Southern Europe - MarketScreener

Oct 07, 2025

Oct 07, 2025

Citius Oncology expands LYMPHIR access through named patient programs - Investing.com

Oct 07, 2025

Oct 07, 2025

Citius Oncology enters exclusive distribution agreement with Integris Pharma S.A. - MarketScreener

Oct 07, 2025

Oct 07, 2025

Citius Oncology Establishes International Access to LYMPHIR™ via Named Patient Programs in Southern Europe - PR Newswire

Oct 07, 2025

Oct 06, 2025

Citius Oncology, Inc. (NASDAQ:CTOR) Sees Significant Decline in Short Interest - Defense World

Oct 06, 2025

Oct 05, 2025

Is a relief rally coming for Citius Oncology Inc. holdersWeekly Stock Analysis & AI Enhanced Market Trend Forecasts - newser.com

Oct 05, 2025

Oct 05, 2025

Is it too late to sell Citius Oncology Inc.July 2025 Final Week & High Yield Stock Recommendations - newser.com

Oct 05, 2025

Oct 05, 2025

Can volume confirm reversal in Citius Oncology Inc.July 2025 Highlights & Low Risk Entry Point Tips - newser.com

Oct 05, 2025

Oct 05, 2025

Using data tools to time your Citius Oncology Inc. exit2025 Earnings Impact & Technical Analysis for Trade Confirmation - newser.com

Oct 05, 2025

Oct 05, 2025

What MACD and RSI say about Citius Oncology Inc.Trade Risk Report & Long-Term Safe Return Strategies - newser.com

Oct 05, 2025

Oct 03, 2025

Citius Oncology, Inc. (NASDAQ:CTOR) Short Interest Down 55.2% in September - MarketBeat

Oct 03, 2025

Oct 03, 2025

Citius Oncology (NASDAQ:CTOR) and Structure Therapeutics (NASDAQ:GPCR) Head to Head Survey - Defense World

Oct 03, 2025

Sep 30, 2025

Citius Oncology (CTOR) Price Target Increased by 100.00% to 6.12 - Nasdaq

Sep 30, 2025